Akoya Biosciences

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

At Akoya, we believe that the exploration of data is the key to unlocking insight and furthering medical science forward. We strive to provide comprehensive and digital solutions that will enable researchers to accelerate their disease research, diagnosis and therapy development.

Our vision is to create predictive cellular models to make clinical decisions faster and more accurately. We strive to provide the best technology tools and insights to advance research and breakthrough treatments.

Akoya has been awarded numerous accolades for its innovative technology platform, including The Artemis Top 50 Medtech Companies and TiE50 Winner in the Silicon Valley Technology Awards.